Azintuxizumab is an anti-SLAMF7 human IgG4kappa monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin[1].
Molecular Weight:
(145.32 kDa)
Purity:
99
CAS Number:
[1826819-57-1]
Target:
ADC Antibody
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted